Theravance Biopharma
TBPH
#6225
Rank
$0.41 B
Marketcap
Cayman Islands
Country
$8.62
Share price
1.53%
Change (1 day)
-22.55%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - Total debt
Total debt on the balance sheet as of March 2024 : $47.9 M
According to Theravance Biopharma 's latest financial reports the company's total debt is $47.9 M. A company’s total debt is the sum of all current and non-current debts.
Theravance Biopharma - Total debt on balance sheet (from 2016 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $49.15 M | -5.75% |
| 2022-12-31 | $52.16 M | -92.21% |
| 2021-12-31 | $0.66 B | -1% |
| 2020-12-31 | $0.67 B | 32.46% |
| 2019-12-31 | $0.51 B | 12.36% |
| 2018-12-31 | $0.45 B | 103.07% |
| 2017-12-31 | $0.22 B | 0.48% |
| 2016-12-31 | $0.22 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $0.07 M | -99.84% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $0.62 B | 1,215.14% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $3.46 M | -92.76% | 🇺🇸 USA |
 Catalent CTLT | $4.99 B | 10,316.88% | 🇺🇸 USA |